| |
 |
|
|
|
|
|
Poster: 205
Visits: 65
Title: Multi-center phase II study with lenalidomide plus rituximab as initial treatment for mantle cell lymphoma: survival update and health-related quality-of-life analysis
Authors: Jia Ruan , P. Martin, B. Shah, S. J. Schuster, S. Smith, P. Christos, R. R. Furman, A.Rodriguez, J. Svoboda, J. Lewis, O. Katz, M. Coleman, J. P. Leonard
Centre: Weill Cornell Medical College
|
|
You must be registered to reply or comment.
|
|
MULTI-CENTER PHASE II STUDY WITH LENALIDOMIDE PLUS RITUXIMAB AS INITIAL TREATMENT FOR MANTLE CELL LYMPHOMA: SURVIVAL UPDATE AND HEALTH-RELATED QUALITY-OF-LIFE ANALYSIS
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
